Alcobra prices $40.14 million public sale of ordinary stock at $6.50

Jefferies and Barclays to be the bookrunning managers for deal

By Devika Patel

Knoxville, Tenn., Nov. 13 – Alcobra Ltd. said it priced a $40.14 million public offering of stock with a $6.02 million greenshoe. The deal was announced Thursday.

The company will sell 6,175,000 ordinary shares at $6.50 apiece. The price per share is an 8.71% discount to the Nov. 12 closing share price of $7.12.

Jefferies LLC and Barclays are the bookrunning managers.

Settlement is expected Nov. 18.

Proceeds will be used for clinical development and general corporate purposes.

The emerging biopharmaceutical company is based in Tel Aviv, Israel.

Issuer:	Alcobra Ltd.
Issue:	Ordinary shares
Amount:	$40,137,500
Greenshoe:	$6,020,625, or 926,250 shares
Shares:	6,175,000
Price:	$6.50
Warrants:	No
Bookrunners:	Jefferies LLC, Barclays
Co-managers:	Oppenheimer & Co. Inc., Roth Capital Partners, LLC, Cantor Fitzgerald & Co.
Announcement date:	Nov. 12
Pricing date:	Nov. 13
Settlement date:	Nov. 18
Stock symbol:	Nasdaq: ADHD
Stock price:	$7.12 at close Nov. 12
Market capitalization:	$125.86 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.